GlassScriptPhysician profile
Remya James
NPI 1497310544
$7,005.53
in general payments reported to CMS, 2019-2025
38 companies · $1,532 in 2025
The $1,532 reported for 2025 was more than what 91% of Gerontology (Nurse Practitioner) providers received nationally (typical 2025 total: $180).
See the full distribution for Gerontology (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $588 · 2022: $616 · 2023: $1,328 · 2024: $2,941 · 2025: $1,532.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,948 · Long Term Medical Supply Or Device Loan: $1,854.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,947.50 |
| Long Term Medical Supply Or Device Loan | $1,853.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $2,659.91 | 2023-2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Teva Pharmaceuticals USA, INC. | $574.73 | 2022-2025 | Austedo Xr, Austedo Xr, Austedo |
| Astrazeneca Pharmaceuticals LP | $379.89 | 2021-2025 | Breztri, Lokelma, Farxiga |
| Otsuka America Pharmaceutical, INC. | $351.94 | 2023-2025 | Rexulti |
| Novo Nordisk INC | $323.01 | 2021-2025 | Rybelsus, Ozempic, Wegovy |
| Tactile Systems Technology INC | $295.91 | 2025 | Flexitouch Plus, Nimbl |
| Amgen INC. | $238.54 | 2024-2025 | Repatha, Repatha, Otezla |
| Janssen Pharmaceuticals, INC | $197.77 | 2021-2025 | Spravato |
| Abbvie INC. | $196.97 | 2021-2024 | |
| Urovant Sciences INC | $163.30 | 2021-2022 | |
| Scilex Pharmaceuticals INC. | $161.88 | 2021-2024 | Ztlido |
| Lilly USA, LLC | $161.14 | 2021-2023 | Jardiance, Mounjaro |
| Organogenesis INC. | $149.68 | 2025 | Affinity, Apligraf, Puraply Wound Matrix |
| Lundbeck LLC | $144.79 | 2023-2025 | Rexulti |
| Sumitomo Pharma America, INC. | $140.83 | 2023-2024 | Gemtesa |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Remya James listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.